InShapeMD’s Innovative Semaglutide Program Tackles Diabetes and Weight Loss Together In Texas
San Angelo, TX, 22nd October 2024, ZEX PR WIRE, Obesity and diabetes often go hand-in-hand, creating a vicious cycle that can significantly impact a person’s health and quality of life. InShapeMD San Angelo is proud to offer a groundbreaking solution: our Semaglutide program. This innovative treatment combines the power of medication with personalized support to help individuals address both obesity and diabetes effectively. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, works by mimicking the body’s natural hormone that regulates appetite and blood
Read more